Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 8 of 31

COMPLETED Early Phase 1

Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Inflammation

NCT06812429
COMPLETED NA

Online Proton Adaptive Radiotherapy

NCT06310655
COMPLETED NA

Examining the Role of Pain in the Link Between Early Childhood Adversity and Psychopathology

NCT06445712
COMPLETED NA

Comparing the Effectiveness of Two Produce Prescription Approaches On Fruit and Vegetable Intake and Food Security, While Exploring Implementation Outcomes Such as Reach, Implementation, Sustainability, and Cost

NCT06263751
TERMINATED NA

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

NCT05513027
COMPLETED Phase 4

Block and Periarticular Injection Study

NCT06410612
COMPLETED NA

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

NCT06236516
COMPLETED NA

Cognitive Enhancement Through Model-based and Individualized Neurostimulation

NCT06235970
COMPLETED NA

Implementation Science to Reduce the Disparity in Tobacco Treatment Among Individuals With Serious Mental Illness

NCT05952401
COMPLETED NA

Patient-centered Educational Material to Improve Colposcopy Adherence

NCT05762757
COMPLETED Phase 1

Barre Exercise in Parkinson's

NCT06203990
TERMINATED Phase 2

Intranasal Ketorolac Trial

NCT06083571
COMPLETED Phase 2

Stellate Ganglion Block for COVID-induced Parosmia

NCT06253806
COMPLETED Phase 1

KET-RO Plus RO DBT for Treatment Resistant Depression

NCT06138691
COMPLETED NA

Pill Bottle vs Reminder App

NCT06034301
TERMINATED NA

Providing Cancer Care Closer to Home for Patients With Multiple Myeloma

NCT05971056
COMPLETED NA

Digital Intervention to Promote Medical Trainee Well-being (OptimalWork Pilot)

NCT06914843
TERMINATED NA

Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia

NCT06789952
COMPLETED Early Phase 1

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT05678348
COMPLETED Early Phase 1

Washington University WU 409: Immune Responses to Rabies Vaccine.

NCT07399951
COMPLETED Phase 1

Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)

NCT05618301
COMPLETED NA

Translating ECHOS2 Into an mHealth Platform

NCT05923242
COMPLETED Early Phase 1

mHealth to Help Pregnant and Postpartum Women in Recovery for Opioid Use Disorder

NCT06701123
COMPLETED NA

Moving Mindfully for Freezing of Gait

NCT05923229
COMPLETED NA

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

NCT05789316
TERMINATED NA

Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors

NCT05769062
COMPLETED Phase 2

Fluvoxamine for Long COVID-19

NCT05874037
COMPLETED NA

Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)

NCT05716542
COMPLETED NA

Visual Aids for Induction of Labor RCT

NCT05671224
COMPLETED NA

Behavioral Activation and Medication Optimization For Improving Perioperative Mental Health In Older Adults Undergoing Oncologic Surgery

NCT05685511
COMPLETED NA

Biofeedback vs Laryngeal Control Therapy in Management of Paradoxical Vocal Fold Motion

NCT05770518
COMPLETED NA

Perioperative Mental Health in Orthopedic Surgery

NCT05697835
TERMINATED Phase 1

Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial)

NCT05049863
COMPLETED

Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c

NCT05725746
COMPLETED NA

Endometriosis Group Care

NCT05622955
COMPLETED Phase 4

Efavirenz (EFV) Intensification

NCT07193875
COMPLETED Phase 1

Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery

NCT05111353
COMPLETED NA

Helping HAND: Healing Anorexia Nervosa Digitally

NCT05499676
COMPLETED NA

Online Educational Tool for Caregivers of Pediatric Oncology Patients

NCT05616572
COMPLETED Phase 2

Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)

NCT05947643
COMPLETED Early Phase 1

Myocardial Perfusion Imaging Galmydar Rest/Stress

NCT05625490
TERMINATED Phase 2

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

NCT05060003
COMPLETED Phase 2

Mandibular Advancement vs Home Treatment for Primary Snoring

NCT05756647
COMPLETED NA

Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures

NCT05575128
COMPLETED NA

A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors

NCT05265715
COMPLETED Phase 4

Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

NCT05541484
COMPLETED Phase 3

THRIVE Feasibility Trial

NCT05346588
COMPLETED NA

Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct

NCT05390580
COMPLETED NA

Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers

NCT05812599
COMPLETED NA

Pain Sensitivity During Puberty

NCT05145595
← Previous Page 8 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

Therapeutic Areas

Obesity 20
Breast Cancer 19
Multiple Myeloma 13
Myelodysplastic Syndromes 13
Alzheimer Disease 10
Parkinson Disease 8
Depression 8
Cancer of the Breast 7
Dementia 7
Insulin Resistance 7

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.